$JHX

James Hardie Industries plc

alphai earnings readQ1 FY27 · AUG 6James Hardie Reports First Quarter FY27 Results; Raises FY27 OutlookVerdict: strong

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

1
2
1
$28.3M
Singh Jesse G
0%
See all $JHX insider activity →
Low

James Hardie (NYSE: JHX) exec sells shares after $11.23 options exercise

James Hardie (JHX) President Jonathan Skelly exercised 50,000 employee stock options at $11.23 per share and sold 65,000 shares at $30.45-$30.46, totaling $1.98M. The options were assumed during the AZEK Company acquisition. Skelly holds 287,721 options and 309,906 shares post-transaction.

Skelly Jonathan sold $2.0M of JHX

Skelly Jonathan (Pres. James Hardie NA) sold 65,000 shares of James Hardie Industries plc (JHX) at an average of $30.46 ($30.45–$30.46, $1.98M total) across 2 trades on 2026-08-25.

James Hardie (NYSE: JHX) director unloads stock after August option exercises

James Hardie (JHX) director Jesse G. Singh exercised 530,100 employee stock options at $11.23 per share and sold 871,557 ordinary shares at an average price of $30 per share on August 21 and 24, 2026. The sales included shares held by trusts where Singh or his spouse serve as trustees.

JHX sentiment & insider activity

Over the past 7 days, alphai's AI scored 4 news stories mentioning JHX (James Hardie Industries plc). Coverage has been balanced: 1 bullish, 2 neutral, and 1 bearish.

Recent JHX coverage spans insider activity, mergers & acquisitions and financial news.

In the last 30 days, JHX insiders filed 7 SEC Form 4 transactions — no purchases and 7 sales ($28.3M). The most active reporter was Singh Jesse G with 5 filings.

What's driving JHX

alphai scores every news story that mentions JHX with an AI model for sentiment and relevance, and aggregates insider trades from James Hardie Industries plc's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $JHX

Score
$JHXHighAI 9/10

Fitch revises James Hardie outlook on European divestiture

Fitch affirmed James Hardie's 'BBB' rating and revised its outlook to Stable from Negative after the company agreed to sell its European business to Holcim for $980M. The deal, expected to close in 2027, includes the sale of Fermacell and the closure of its European fiber cement business. Fitch expects James Hardie's EBITDA leverage to decrease to 2.5x by FYE 2027, supported by debt paydown and sale proceeds. The European operations contributed 11.5% of revenue and 7.2% of EBITDA in fiscal 2026.

$JHXLow

James Hardie Industries plc (JHX): Submission of Matters to a Vote of Security Holders

James Hardie Industries plc (JHX) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 3.03 - Material Modification to Rights of Security Holders. The information set forth under Item 5.03 below is incorporated by reference in this Item 3.03. Item 5.03 - Amendments or Articles of Incorporation or Bylaws; Change in Fiscal Year. At the Annual Meeting (as defined

$JHXHighAI 9/10

James Hardie ditches Europe, selling out to Holcim in $1.38b deal

James Hardie Industries is selling its Fermacell business in Europe to Holcim for €840 million ($1.38 billion) and exiting the region. The company will focus on its North American operations. According to James Hardie, the deal marks the end of its nine-year ownership of Fermacell.

$JHXHighAI 9/10

James Hardie Industries plc: James Hardie Announces Strategic Divestiture of European Operations, Including Sale of Fermacell to Holcim for €840 Million

James Hardie (JHX) is selling its European operations, including Fermacell, to Holcim (HOLN) for €840 million. The company will also close its European fiber cement business. Proceeds will be used to repay debt and fund a $250 million share buyback program. The deal is expected to close in early 2027.

$JHXHigh

James Hardie Industries plc (JHX): Entry into a Material Definitive Agreement

James Hardie Industries plc (JHX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 James Hardie Announces Strategic Divestiture of European Operations, Including Sale of Fermacell to Holcim for €840 Million Transaction expected to accelerate deleveraging, support return of capital to shareholders, and be accretive to margin profile and ROIC Separat

Related tickers